跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HRZ Pedia DT - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
HRZ Pedia DT
Approved
STANDARD
HRZ Pedia DT
Oxalis Labs
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
43f0d110359e2586
Company
Oxalis Labs
Type
Standard
Approval Details
Approval Id
43f0d110359e2586
Drug Approval Philippines Name
HRZ Pedia DT
Product Name
HRZ Pedia DT
Registration Number
DRP-12569
Brand Name
HRZ Pedia DT
Generic Name
Rifampicin + Isoniazid + Pyrazinamide
Dosage Form
Dispersible Tablet
Dosage Strength
75 mg/50 mg/150 mg
Manufacturer
Oxalis Labs
Importer
UNILAB, Inc.
Distributor
UNILAB, Inc.
Company Detail Path
/organization/oxalis-labs
Issuance Date
06 September 2022
Expiry Date
06 September 2027
Pharmacologic Category
Antituberculosis
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
43f0d110359e2586
Type
Standard
Back to Philippines FDA Approvals